Cases & Deals

  • Home
  • Practices
  • RaNA Therapeutics (now known as Translate Bio) acquires Shire's messenger RNA therapy platform

Share

RaNA Therapeutics (now known as Translate Bio) acquires Shire's messenger RNA therapy platform

September 2016

Client(s) RaNA Therapeutics, Inc.

Jones Day acted as IP counsel to RaNA Therapeutics, Inc. (now known as Translate Bio) in connection with its acquisition of Shire Pharmaceuticals' messenger RNA therapy platform (MRT), with lead programs in cystic fibrosis and urea cycle disorders.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.